Lupin Licenses Diarrhea Drug From Romark To Market In U.S.
This article was originally published in PharmAsia News
Executive Summary
Lupin and U.S.-based Romark Laboratories have signed a licensing agreement for marketing the already-approved Alinia (nitazoxanide) diarrhea drug in the U.S.